| Rank | Logo | Company | Market Cap | Country |
|---|---|---|---|---|
| 1 |  | Eli Lilly | $821.17 B | USA |
| 2 |  | Johnson & Johnson | $572.59 B | USA |
| 3 |  | AbbVie | $364.64 B | USA |
| 4 |  | Roche | $325.18 B | Switzerland |
| 5 |  | AstraZeneca | $292.89 B | UK |
| 6 |  | Novartis | $286.46 B | Switzerland |
| 7 |  | Merck | $282.34 B | USA |
| 8 |  | Amgen | $188.63 B | USA |
| 9 |  | Gilead Sciences | $175.17 B | USA |
| 10 |  | Thermo Fisher Scientific | $174.67 B | USA |
| 11 |  | Novo Nordisk | $165.29 B | Denmark |
| 12 |  | Pfizer | $155.86 B | USA |
| 13 |  | Bristol-Myers Squibb | $118.33 B | USA |
| 14 |  | Vertex Pharmaceuticals | $116.36 B | USA |
| 15 |  | Sanofi | $109.49 B | France |
| 16 |  | GSK plc | $105.18 B | UK |
| 17 |  | Chugai Pharmaceutical | $90.19 B | Japan |
| 18 |  | Regeneron Pharmaceuticals | $77.96 B | USA |
| 19 |  | Takeda Pharmaceutical | $57.21 B | Japan |
| 20 |  | UCB | $55.34 B | Belgium |
| 21 |  | Jiangsu Hengrui Medicine | $53.71 B | China |
| 22 |  | Zoetis | $51.11 B | USA |
| 23 |  | Samsung Biologics | $50.27 B | S. Korea |
| 24 |  | CSL | $47.60 B | Australia |
| 25 |  | Sun Pharmaceutical | $45.06 B | India |
| 26 |  | Bayer | $43.77 B | Germany |
| 27 |  | Galderma Group | $42.41 B | Switzerland |
| 28 |  | Argenx | $42.35 B | Netherlands |
| 29 |  | Lonza | $42.10 B | Switzerland |
| 30 |  | WuXi AppTec | $41.64 B | China |
| 31 |  | Alnylam Pharmaceuticals | $41.25 B | USA |
| 32 |  | Otsuka Holdings | $35.84 B | Japan |
| 33 |  | Teva Pharmaceutical Industries | $34.28 B | Israel |
| 34 |  | Daiichi Sankyō | $33.73 B | Japan |
| 35 |  | Sandoz Group | $33.58 B | Switzerland |
| 36 |  | BeOne Medicines | $32.47 B | USA |
| 37 |  | Agilent Technologies | $31.60 B | USA |
| 38 |  | Insmed | $31.03 B | USA |
| 39 |  | Celltrion | $29.75 B | S. Korea |
| 40 |  | Astellas Pharma | $27.03 B | Japan |
| 41 |  | Biogen | $26.91 B | USA |
| 42 |  | Royalty Pharma | $26.33 B | UK |
| 43 |  | DexCom | $26.23 B | USA |
| 44 |  | Hansoh Pharma | $25.00 B | China |
| 45 |  | Novonesis | $24.65 B | Denmark |
| 46 |  | United Therapeutics | $23.09 B | USA |
| 47 |  | BioNTech | $22.44 B | Germany |
| 48 |  | LabCorp | $21.89 B | USA |
| 49 |  | Moderna | $20.68 B | USA |
| 50 |  | Roivant Sciences | $19.89 B | UK |
| 51 |  | Exact Sciences | $19.83 B | USA |
| 52 |  | Revolution Medicines | $19.67 B | USA |
| 53 |  | Illumina | $19.35 B | USA |
| 54 |  | Incyte | $18.49 B | USA |
| 55 |  | Innovent Biologics | $18.16 B | China |
| 56 |  | Shionogi | $18.15 B | Japan |
| 57 |  | WuXi Biologics | $18.06 B | China |
| 58 |  | Divis Laboratories | $17.07 B | India |
| 59 |  | Sichuan Biokin Pharmaceutical | $16.29 B | China |
| 60 |  | Genmab | $15.88 B | Denmark |
| 61 |  | Viatris | $15.54 B | USA |
| 62 |  | Torrent Pharmaceuticals | $15.34 B | India |
| 63 |  | Ipsen | $14.52 B | France |
| 64 |  | Akeso | $13.77 B | China |
| 65 |  | Ascendis Pharma | $13.74 B | Denmark |
| 66 |  | BridgeBio Pharma | $13.58 B | USA |
| 67 |  | Swedish Orphan Biovitrum | $13.53 B | Sweden |
| 68 |  | Regencell Bioscience | $13.35 B | Hong Kong |
| 69 |  | Medpace | $13.08 B | USA |
| 70 |  | CSPC Pharmaceutical Group Limited | $13.05 B | China |
| 71 |  | Neurocrine Biosciences | $13.01 B | USA |
| 72 |  | Alteogen | $12.74 B | S. Korea |
| 73 |  | bioMérieux | $12.66 B | France |
| 74 |  | Elanco | $12.48 B | USA |
| 75 |  | Summit Therapeutics | $12.18 B | UK |
| 76 |  | Ionis Pharmaceuticals | $11.78 B | USA |
| 77 |  | Dr. Reddy's Laboratories | $11.77 B | India |
| 78 |  | Orion Corporation | $11.46 B | Finland |
| 79 |  | Avidity Biosciences | $11.24 B | USA |
| 80 |  | Jazz Pharmaceuticals | $11.19 B | Ireland |
| 81 |  | Lupin Limited | $11.08 B | India |
| 82 |  | Exelixis | $11.06 B | USA |
| 83 |  | Financière de Tubize | $10.90 B | Belgium |
| 84 |  | Cipla | $10.77 B | India |
| 85 |  | BioMarin Pharmaceutical | $10.58 B | USA |
| 86 |  | Recordati | $10.50 B | Italy |
| 87 |  | Madrigal Pharmaceuticals | $10.41 B | USA |
| 88 |  | Abivax | $9.74 B | France |
| 89 |  | Fosun Pharma | $9.74 B | China |
| 90 |  | Revvity | $9.72 B | USA |
| 91 |  | Shenzhen Salubris Pharmaceuticals | $9.53 B | China |
| 92 |  | Zydus Lifesciences | $9.49 B | India |
| 93 |  | ImmunityBio | $9.06 B | USA |
| 94 |  | Huadong Medicine (HD Medicine) | $8.98 B | China |
| 95 |  | Tempus AI | $8.71 B | USA |
| 96 |  | Mankind Pharma | $8.63 B | India |
| 97 |  | Baxter | $8.57 B | USA |
| 98 |  | Eisai | $8.50 B | Japan |
| 99 |  | Qiagen | $8.37 B | Netherlands |
| 100 |  | Haisco Pharmaceutical Group | $8.35 B | China |
